Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

HTTPS

Secure .gov websites use HTTPS
A lock (LockA locked padlock) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

  • About HHS
  • Programs & Services
  • Grants & Contracts
  • Laws & Regulations
  • Radical Transparency
  • Big Wins
  • About OHRP
  • Regulations, Policy & Guidance
  • Education & Outreach
  • Compliance & Reporting
  • News & Events
  • Register IRBs & Obtain FWAs
  • SACHRP Committee
  • International
Breadcrumb
  1. HHS
  2. OHRP
  3. Regulations, Policy & Guidance
  4. Guidance
  5. Informed Consent, Legally Effective and Prospectively Obtained (OPRR Letter, 1993)
  • Belmont Report
  • Regulations
    • 45 CFR 46
      • Subpart B
      • Subpart C
      • Subpart D
      • Subpart E
      • List of Expedited Categories (1998)
    • Revision of the Common Rule
      • Preamble to the Revised Common Rule (2018 Requirements)
      • Path to Revising the Common Rule (2011–2018)
      • Explanation of Terminology
  • Decision Charts
    • Pre-2018 Requirements Decision Charts
    • 2018 Requirements Decision Charts
  • Guidance
    • Alphabetical List
    • Frequently Asked Questions
      • 2018 Requirements FAQs
      • 45 CFR 46 FAQs
      • Assurance Process FAQs
      • Children: Research with Children FAQs
      • Exempt Research Determination FAQs
      • Informed Consent FAQs
      • Investigator Responsibilities FAQs
      • IRB Registration Process FAQs
      • Prisoner Research FAQs
      • Quality Improvement Activities FAQs
    • Draft Guidance
    • Informed Consent
    • Institutional Issues
    • For Investigators
    • Vulnerable Populations
    • Protocol Review
    • Biological Materials & Data
    • Correspondence
  • Requests for Comments
  • Informed Consent Posting
    • Uploading Informed Consent Documents
    • Informed Consent Posting Guidance
  • Single IRB Exception Determinations
    • Background
    • November 2019 Exception Determination
    • October 2020 Exception Determination
  • Subpart C Certification Request to OHRP
  • Regulations & Policy Archived Materials

Informed Consent, Legally Effective and Prospectively Obtained (OPRR Letter, 1993)

Number 93-3
Human Subject Protections

OPRR REPORTS

August 12, 1993
NIH PHS HHS

Subject: Informed Consent--Legally Effective and Prospectively Obtained

Dear Colleague:

This letter is being forwarded to Institutional Officials and Institutional Review Board (IRB) Chairs throughout the country. Its purpose is to reiterate the mandate for obtaining legally effective informed consent prospectively from each research subject or the subject's legally authorized representative. This requirement is applicable to all research activities conducted or supported by the Department of Health and Human Services (HHS) and is stipulated in the HHS regulations for the protection of human research subjects (45 CFR 46.116). The requirement is equally applicable to research which is not supported or conducted by HHS, if the research is carried out in accord with a Multiple Project Assurance (MPA) approved by the Office for Protection for Research Risks (OPRR), and no alternative procedures were presented and approved in the applicable MPA.

There are only two circumstances under which the regulations give IRBs authority to waive the required consent. The first waiver authority is applicable only to research activities designed to study certain aspects of public benefit or service programs; the conditions under which this waiver may be authorized by an IRB are detailed at 45 CFR 46.116(c). The second waiver authority is described at 45 CFR 46.116(d) as follows:

An IRB may approve a consent procedure which does not include, or which alters, some or all of the elements of informed consent set forth in this section, or waive the requirements to obtain informed consent provided the IRB finds and documents that:

  1. the research involves no more than minimal risk to the subjects;
  2. the waiver or alteration will not adversely affect the rights and welfare of the subjects;
  3. the research could not practicably be carried out without the waiver or alteration; and
  4. whenever appropriate, the subjects will be provided with additional information after participation.

Recently, we have become aware of the use of a consent procedure referred to as "deferred consent" or "ratification." Informed consent procedures which provide for other than legally effective and prospectively obtained consent, fail to constitute informed consent under the HHS regulations for the protection of human research subjects. Similarly, the waiving of informed consent, using a method other than that requiring the IRB findings and IRB documentation specified at 45 CFR 46.116(c) or (d), is not in compliance with the regulations.

I urge your careful review of these requirements as they may apply to your institution's and your IRB's actions and procedures. If you have any questions as you carry out this task, please contact Bill Dommel, OPRR's Senior Policy Advisor, at (301) 496-7005.

Gary B. Ellis, Ph.D.
Director
Office for Protection from Research Risks

Content created by Office for Human Research Protections (OHRP)
Content last reviewed March 21, 2016
Back to top

Subscribe to Email Updates

Receive the latest updates from the Secretary and Press Releases.

Subscribe
  • Contact HHS
  • Careers
  • HHS FAQs
  • Nondiscrimination Notice
  • Press Room
  • HHS Archive
  • Accessibility Statement
  • Privacy Policy
  • Budget/Performance
  • Inspector General
  • Web Site Disclaimers
  • EEO/No Fear Act
  • FOIA
  • The White House
  • USA.gov
  • Vulnerability Disclosure Policy
HHS Logo

HHS Headquarters

200 Independence Avenue, S.W.
Washington, D.C. 20201
Toll Free Call Center: 1-877-696-6775​

Follow HHS

Follow Secretary Kennedy